New York Genome Center (NYGC)

Genome sequencing: nygc has one of the largest volume whole Genome sequencing programs in New York. In the past ten years, nygc's sequencing laboratory has sequenced over 102,800 whole Genome samples. Nygc has acquired two of the newest illumina novaseq x systems sequencers, each with the capacity to sequence twenty thousand human genomes annually. This state-of-the-art sequencing technology enables nygc to conduct large-scale genomics projects with great speed and sample volumes, and to explore the Genome in more depth with greater efficiency. In addition, nygc operates an oxford nanopore promethion sequencer for long read sequencing, and continued to test and validate a high-throughput sequencer from ultima genomics (the ug100). See schedule o.

Clinical sequencing: nygc is authorized by the New York state department of health to offer the following approved clinical tests through its clep/clia certified clinical laboratory: constitutional whole Genome sequencing for undiagnosed disease, constitutional wholegenome sequencing for predispositional genetic screening, oncology whole Genome and transcriptome sequencing, constitutional whole exome sequencing, targeted variant testing using sanger sequencing, oncology whole exome and transcriptome sequencing, and the smash genomic assay.